Predict your next investment

HEALTHCARE | Biotechnology
curalogic.com

See what CB Insights has to offer

Founded Year

2004

Stage

IPO | IPO

Total Raised

$7.52M

Date of IPO

6/1/2006

About Curalogic

Developer of pharmaceuticals for the treatment of allergic diseases. The company develops oral immunotherapy products based on the targeted delivery of allergens with potential applications in the treatment of ragweed, grass, cat, and house dust mite allergies.

Curalogic Headquarter Location

Amagertov 29A 4th Floor

Copenhagen, 1160,

Denmark

45 3311 4101

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.